Abstract B061: In vivo benchmarking of trastuzumab deruxtecan (T-DXd) activity in panel of 400 XPDX models
Year: 2025
Type: conference-abstract
Source: Molecular Cancer Therapeutics
Authors: Alyssa Simonson, Johnnie Flores, Jennifer Garcia, Peter Forofontov, Crystal Moreno, Esteban Wiggins, Sarah Lopez, Amarissa Rojas, Mia Lopez, Kirstin McCormick, Raymona Artis, Amy Fredrickson, Jim Lund, Christopher Nelson, Ian Sturgill, Ashley Jamison, Ronan Pleass, Garrett Mercer, Kyriakos Papadopoulos, Amita Patnaik, Victor Moreno, Emiliano Calvo, David Smith, Andrew Cunningham, Chris Takimoto, Michael Wick
Institution: South Texas Accelerated Research Therapeutics
Language: English
Topic: HER2/EGFR in Cancer Research
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W4415449759
Cites:
Cited by:
Related to: